Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1((27-35))

Journal of Experimental Medicine

Volumn 184, Issue 2, 1996, Pages 647-657

  Loftus, Douglas J ^a,b   Castelli, Chiara ^a   Clay, Timothy M ^b   Squarcina, Paola ^a   Marincola, Francesco M ^b   Nishimura, Michael I ^b   Parmiani, Giorgio ^a   Appella, Ettore ^a   Rivoltini, Licia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; MELANOMA ANTIGEN;

ANTIGEN DETECTION; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOLOGY; CONGENITAL DISORDER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0029788301     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.2.647     Document Type: Article

References (56)

1. Boon, T., T.F. Gajewski, and P.G. Coulie. 1995. From defined tumor antigens to effective immunization? Immunol. Today. 16:334-336.
2. Coulie, P.G., F. Lehmann, B. Lethe, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
3. Wolfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wolfel, H.E. Klehmann, E. De Plaen, T. Hankeln, K. H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4α-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science (Wash. DC). 269:1281-1284.
4. Robbins, P.F., M. El-Gamil, Y.F. Li, Y. Kawakami, D. Loftus, E. Appella, and S.A. Rosenberg. 1996. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185-1192.
5. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC). 254:1643-1647.
6. Boel, P., C. Wildmann, M.L. Sensi, R. Brasseur, J.C. Renauld, P. Coulie, T. Boon, and P. van der Bruggen. 1995. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity. 2: 167-175.
7. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689-698.
8. Brichard, V., A. Van Pel, T. Wolfel, C. Wolfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
9. Coulie, P.G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversairi, S. Mattei, E. De Plaen, C. Lurquin, J.P. Szikora et al., 1994. A new gene coding for a differentiation antigen recognized by antologous cytolytic T lymphocytes on HLA-A2 melanomas J. Exp. Med. 180:35-42.
10. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, L. Rivoltini, S.L. Topalian, T. Miki, and S.A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA. 91:3515-3519.
11. Cox, A.L., J. Skipper, Y. Chen, R.A. Henderson, T.L. Darrow, J. Shabanowitz, V.H. Engelhard, D.F. Hunt, and C.J. Slingluff. 1994. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Wash. DC). 264:716-719.
12. Kawakami, Y., S. Eliyahu, C.H. Delgado, P.F. Robbins, K. Sakaguchi, E. Appella, J.R. Yannelli, G.J. Adema, T. Miki, and S.A. Rosenberg. 1994. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA. 91:6458-6562.
13. Wang, R.F., P.F. Robbins, Y. Kawakami, X.Q. Kang, and S.A. Rosenberg. 1995. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes [published erratum appears in J. Exp. Med. 181:1261]. J. Exp. Med. 181:799-804.
14. Marincola, F.M., D. Venzon, D. White, J.T. Rubin, M.T. Lotze, T.B. Simonis, J. Balkissoon, S.A. Rosenberg, and D.R. Parkinson. 1992. HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy [published errata appear in Cancer Res. 1993 53:3846 and 1993 53:6079]. Cancer Res. 52:6561-6566.
15. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P.F. Robbins, L. Rivoltini, J.R. Yannelli, E. Appella, and S.A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347-352.
16. Spagnoli, G.C., C. Schaefer, T.E. Willimann, T. Kocher, A. Amoroso, A. Juretic, M. Zuber, U. Luscher, F. Harder, and M. Heberer. 1995. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Int. J. Cancer. 64:309-315.
17. Rivoltini, L., Y. Kawakami, K. Sakaguchi, S. Southwood, A. Sette, P.F. Robbins, F.M. Marincola, M.L. Salgaller, J.R. Yannelli, E. Appella, and S.A. Rosenberg. 1995. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol. 154:2257-2265.
18. Salgaller, M.L., A. Afshar, F.M. Marincola, L. Rivoltini, Y. Kawakami, and S.A. Rosenberg. 1995. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res. 55:4972-4979.
19. Stevens, E.J., L. Jacknin, P.F. Robbins, Y. Kawakami, M. El-Gamil, S.A. Rosenberg, and J.R. Yannelli. 1995. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J. Immunol. 154:762-771.
20. Bhardwaj, V., V. Kumar, H.M. Geysen, and E.E. Sercarz. 1993. Degenerate recognition of a dissimilar antigenic peptide by myelin basic protein-reactive T cells. J. Immunol. 151: 5000-5010.
21. Garza, K.M., and K.S.K. Tung. 1995. Frequency of molecular mimicry among T cell peptides as the basis for autoimmune disease and autoantibody induction. J. Immunol. 155: 5444-5448.
22. Shimoda, S., M. Nakamura, H. Ishibashi, K. Hayashida, and Y. Niho. 1995. HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J. Exp. Med. 181:1835-1845.
23. Quaratino, S., C.J. Thorpe, P.J. Travers, and M. Londei. 1995. Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. Proc. Natl. Acad. Sci. USA. 92:10398-10402.
24. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
25. Ohashi, P.S., S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner. 1991. Ablation of tolerance and induction of diabetes by virusinfection in viral antigen transgenic mice. Cell. 65: 305-317.
26. Oldstone, M.B.A. 1990. Molecular mimicry and autoimmune disease. Cell. 50:819-820.
27. Cole, D.J., D.P. Weil, P. Shamamian, L. Rivoltini, Y. Kawakami, S. Topalian, C. Jennings, S. Eliyahu, S.A. Rosenberg, and M.I. Nishimura. 1994. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope [published erratum appears in Cancer Res. 1994 54: 6014]. Cancer Res. 54:5265-5268.
28. Ljunggren, H.G., N.J. Stam, C. Ohlen, J.J. Neefjes, P. Hoglund, M.T. Heemels, J. Bastin, T.N. Schumacher, A. Townsend, K. Karre, and H. Ploegh. 1990. Empty MHC class I molecules come out in the cold. Nature (Lond.). 346: 476-480.
29. Milford, E.L., L.J. Kennedy, S.Y. Yang, B. Dupont, J.-M. Lalouel, and E.J. Yunis. 1987. Serological characterization of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system. In Immunobiology of HLA, Vol. 1 Histocompatibility Testing. B. Dupont, editor. Springer, New York. 19.
30. Weir, J.P., M. Bennet, E.M. Allen, K.L. Elkins, S. Martin, and B.T. Rouse. 1989. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J. Gen. Virol. 70: 2587-2594.
31. Rivoltini, L., D.J. Loftus, K. Barracchini, F. Arienti, A. Mazzocchi, W.E. Biddison, M. Salgaller, E. Appella, G. Parmiani, and F. Marincola. 1996. Binding and presentation of peptides derived from melanoma antigens MART-1 and gp100 by HLA-A2 subtypes: implications for peptide-based immunotherapy. J. Immunol. In press.
32. Smith, G.L., J.Z. Levin, J. Palese, and H. Moss. 1987. Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology. 160:336-345.
33. Salvi, S., F. Segalla, S. Rao, F. Arienti, M. Sartori, G. Brantina, E. Caronno, A. Anichini, C. Clemente, G. Parmiani, and M. Sensi. 1995 Overexpression of the T-Cell Receptor beta-chain variable region TCRBV24 in HLA-A2-matched primary human melanomas. Cancer Res. 55:3374-3379.
34. Genevee, C., A. Diu, J. Nierat, A. Caignard, P. Dietrich, L. Ferradini, S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur. J. Immunol. 22:1261-1269.
35. Wei, S., P. Charmley, M.A. Robinson, and P. Concannon. The extent of the human germline T-cell receptor V beta gene segment repertoire. 1994. Immunogenetics. 40:27-36.
36. Kast, W.M., R.M. Brandt, J. Sidney, J.W. Drijfhout, R.T. Kubo, H.M. Grey, C.J. Melief, and A. Sette. 1994. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J. Immunol. 152:3904-3912.
37. Pearson, W.R., and D.J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA. 85:2444-2448.
38. Data made available and distributed electronically by Protein Information Resource (PIR), National Biomedical Research Foundation, Washington, D.C. 20007, USA.
39. Zuckerman, F.A., L. Zsak, T.C. Mettenleiter, and T. Ben-Porat. 1990. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes. J. Virol. 64:802-812.
40. Martin, S., C.M. Mercadal, J.P. Weir, and B.T. Rouse. 1993. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization. Viral Immunol. 6:21-33.
41. Sensi, M., and G. Parmiani. 1995. Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses. Immunol. Today. 16:588-595.
42. Sensi, M., C. Traversari, M. Radrizzani, S. Salvi, C. Maccalli, R. Mortarini, L. Rivoltini, C. Farina, G. Nicolini, T. Wolfel et al. 1995. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc. Natl. Acad. Sci. USA. 92: 5674-5678.
43. Madden, D.R., D.N. Garboczi, and D.C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2 [published erratum appears in Cell. 1994 76:410]. Cell. 75: 693-708.
44. Stern, L.J., J.H. Brown, T.S. Jardetzky, J.C. Gorga, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature (Lond.). 368:215-221.
45. Whitley, R.J. 1994. Herpes simplex virus infections. In Herpesvirus infections. R. Glaser and J. F. Jones, editors. Marcel Dekker, New York. 1-57.
46. Borysiewicz, L.K., and J.G. Sissons. 1994. Cytotoxic T cells and human herpes virus infections. Curr. Top. Microbiol. Immunol. 189:123-150.
47. Marrack, P., J. McCormack, and J. Kappler. 1989. Presentation of antigen, foreign major histocompatibility complex proteins and self by thymus cortical epithelium. Nature (Lond.). 338:503-505.
48. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1994. Specificity and flexibility in thymic selection. Nature (Lond.). 369: 750-752.
49. Dunkley, M., R. Pabst, and A. Cripps. 1995. An important role for intestinally derived T cells in respiratory defence. Immun. Today. 16:231-236.
50. Sztein, M.B., M.K. Tanner, Y. Polotsky, J.M. Orenstein, and M.M. Levine. 1995. Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans. J. Immunol. 155:3987-3993.
51. - subset. J. Exp. Med. 177:1763-1771.
52. Schwartz, R.H. 1990. A cell culture model for T lymphocyte clonal anergy. Science (Wash. DC). 248:1349-1356.
53. Ferrone, S., and F.M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16: 487-494.
54. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340-347.
55. Sette, A., J. Alexander, J. Ruppert, K. Snoke, A. Franco, G. Ishioka, and H.M. Grey. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12:413-431.
56. + T cells by a self-derived peptide. Nature (Lond.). 378:295-298.